Earlier Life Adiposity Trajectories Linked to NAFLD in Teens

This article originally appeared here.
Share this content:
Earlier Life Adiposity Trajectories Linked to NAFLD in Teens
Earlier Life Adiposity Trajectories Linked to NAFLD in Teens

THURSDAY, Jan. 8, 2015 (HealthDay News) -- Earlier life trajectories of adiposity are associated with nonalcoholic fatty liver disease (NAFLD) in adolescents, according to a study published in the January issue of the Journal of Gastroenterology and Hepatology.

Oyekoya T. Ayonrinde, M.B.B.S., from the University of Western Australia in Perth, and colleagues examined the correlations between NAFLD diagnosed during adolescence and earlier life trajectories of anthropometry in a population-based cohort. Questionnaires and liver ultrasound were used to assess NAFLD in 1,170 adolescents aged 17 years.

The researchers found that 15.2 percent of adolescents were diagnosed with NAFLD. There was no association for birth anthropometry, including birth weight, skinfold thickness, and ponderal index, with NAFLD. Adiposity differences between 17-year-olds with and without NAFLD were evident from age 3 years. There were correlations for greater adiposity trajectories for weight, body mass index, skinfold thickness, mid-arm circumference, and chest circumference from age 3 onward with NAFLD diagnosis and severity of hepatic steatosis at age 17 years, particular in males (P < 0.05). For each adiposity measure, the strength of associations increased with age after 3 years (all P < 0.001).

"Trajectories of childhood adiposity are associated with NAFLD," the authors write. "Exploration of clinically relevant risk factors and preventative measures for NAFLD should begin during childhood."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »